726 related articles for article (PubMed ID: 19493541)
1. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.
Dardiotis E; Koutsou P; Zamba-Papanicolaou E; Vonta I; Hadjivassiliou M; Hadjigeorgiou G; Cariolou M; Christodoulou K; Kyriakides T
J Neurol Sci; 2009 Sep; 284(1-2):158-62. PubMed ID: 19493541
[TBL] [Abstract][Full Text] [Related]
2. Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden.
Soares ML; Coelho T; Sousa A; Holmgren G; Saraiva MJ; Kastner DL; Buxbaum JN
Eur J Hum Genet; 2004 Mar; 12(3):225-37. PubMed ID: 14673473
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease.
Soares ML; Coelho T; Sousa A; Batalov S; Conceição I; Sales-Luís ML; Ritchie MD; Williams SM; Nievergelt CM; Schork NJ; Saraiva MJ; Buxbaum JN
Hum Mol Genet; 2005 Feb; 14(4):543-53. PubMed ID: 15649951
[TBL] [Abstract][Full Text] [Related]
4. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus.
Dardiotis E; Koutsou P; Papanicolaou EZ; Vonta I; Kladi A; Vassilopoulos D; Hadjigeorgiou G; Christodoulou K; Kyriakides T
Amyloid; 2009 Mar; 16(1):32-7. PubMed ID: 19291512
[TBL] [Abstract][Full Text] [Related]
6. Amyloidogenic transthyretin Val30Met homozygote showing unusually early-onset familial amyloid polyneuropathy.
Tojo K; Sekijima Y; Machida K; Tsuchiya A; Yazaki M; Ikeda S
Muscle Nerve; 2008 Jun; 37(6):796-803. PubMed ID: 18506713
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis of familial amyloid polyneuropathy type I in Argentina].
Pérez G; Romero MC; Trigo P; Lendoire J; Imventarza O; Nesse A
Medicina (B Aires); 2008; 68(4):273-81. PubMed ID: 18786882
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.
Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M
J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945
[TBL] [Abstract][Full Text] [Related]
9. TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?
Bonaïti B; Olsson M; Hellman U; Suhr O; Bonaïti-Pellié C; Planté-Bordeneuve V
Eur J Hum Genet; 2010 Aug; 18(8):948-52. PubMed ID: 20234390
[TBL] [Abstract][Full Text] [Related]
10. On the origin of the transthyretin Val30Met familial amyloid polyneuropathy.
Zaros C; Genin E; Hellman U; Saporta MA; Languille L; Wadington-Cruz M; Suhr O; Misrahi M; Planté-Bordeneuve V
Ann Hum Genet; 2008 Jul; 72(Pt 4):478-84. PubMed ID: 18460047
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.
Cardoso I; Saraiva MJ
FASEB J; 2006 Feb; 20(2):234-9. PubMed ID: 16449795
[TBL] [Abstract][Full Text] [Related]
12. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
13. [Application to transthyretin analysis].
Ueda M; Ando Y
Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
Planté-Bordeneuve V; Ferreira A; Lalu T; Zaros C; Lacroix C; Adams D; Said G
Neurology; 2007 Aug; 69(7):693-8. PubMed ID: 17698792
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of ATTRV30M neuropathy in Cyprus and the modifier effect of complement C1q on the age of disease onset.
Andreou S; Panayiotou E; Michailidou K; Pirpa P; Hadjisavvas A; El Salloukh A; Barnes D; Antoniou A; Agathangelou P; Papastavrou K; Christodoulou K; Tanteles GA; Kyriakides T
Amyloid; 2018 Dec; 25(4):220-226. PubMed ID: 30572722
[TBL] [Abstract][Full Text] [Related]
16. Discordant penetrance of the trait for familial amyloidotic polyneuropathy in two pairs of monozygotic twins.
Holmgren G; Wikström L; Lundgren HE; Suhr OB
J Intern Med; 2004 Nov; 256(5):453-6. PubMed ID: 15485482
[TBL] [Abstract][Full Text] [Related]
17. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
Berg I; Thor S; Hammarström P
Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
[TBL] [Abstract][Full Text] [Related]
18. Finding of vascular amyloid TTR in inferior nasal concha in a patient with FAP TTRVal30Met.
Munar-Ques M; Martinez-Nadal J; Torres-Rovira JJ; Sole M; Zabay-Becerril JM; Mulet-Ferrer JM
Amyloid; 2008 Dec; 15(4):272-4. PubMed ID: 19065300
[TBL] [Abstract][Full Text] [Related]
19. [Clinical phenotype of Charcot-Marie-Tooth disease (CMT) and familial amyloid polyneuropathy (FAP)].
Sobue G
Rinsho Shinkeigaku; 2003 Nov; 43(11):769-74. PubMed ID: 15152460
[TBL] [Abstract][Full Text] [Related]
20. Familial amyloid polyneuropathy in Korea: the first case report with a proven ATTR Lys35Asn gene.
Ryu JK; Baik HW; Bae JS; Hwang TJ; Paik SY; Yu HJ; Choi BO; Takei Y; Ikeda S
Amyloid; 2005 Mar; 12(1):62-4. PubMed ID: 16076613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
